Schedule 13G ownership disclosure
TALARIS THERAPEUTICS INC
Security class unavailable · CUSIP: 87410C104
Event date: 2023-04-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.9700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001567619-23-005808
- Form type
- SC 13G
- Filer
- BML Investment Partners, L.P.
- CIK
- CIK 1373604
- Filed
- Apr 27, 2023
- Reporting period
- Apr 17, 2023
- Description
- Schedule 13G beneficial ownership